Managing Multiple Medications – Polypharmacy

Many health care professionals have had limited education on supportive care topics and have learned on the job. The guidelines and literature continue to advance supportive oncology care. The Coleman Supportive Oncology Collaborative developed this set of activities to describe guideline-based care and provide ways to incorporate it into patient care.

Content was reviewed and updated 9/29/2023.

Target Audience

This activity is designed to meet the educational needs of physicians, nurses, physician assistants, pharmacists, and other health care professionals who care for patients with cancer.

Learning Objectives

Following this program, participants should be able to:

  • Describe polypharmacy and roles of pharmacists and medical oncologists in optimizing patient’s medications
  • Assess patient factors for medication review:  stage, prognosis, comorbidities, non-cancer life expectancy
  • Examine medications commonly used for supportive care that are a concern, informed by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Older Adult Oncology and Palliative Care

You may also be interested in

Caring for Older Adults with Cancer

Many health care professionals have had limited education on supportive care topics and have learned on the job. The guidelines and literature continue to advance supportive oncology care.
Recorded Presentations from the NCCN 2023 Pharmacy Updates Webinar Series

The availability of new therapeutic options and emergence of novel therapies continues to dramatically impact the oncology landscape.  The rapid integration of these agents into treatment for various tumor types can be challenging for clinicians.
Additional information
Supporters: 

This activity is supported by a grant from The Coleman Foundation.

Course summary
Available credit: 
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Course opens: 
08/04/2022
Course expires: 
08/04/2025
Cost:
$0.00
Part of: 
Supportive Oncology Care

Joanna Martin, MD
Palliative Physician and Geriatrician
Jesse Brown Veterans’ Affairs Medical Center
Northwestern Medical Group

Patrick J. Fleming Jr., PharmD, BCOP
Medical Science Liaison
Servier

Christina Mactal Haaf, PharmD, BCOP, BCPS
Clinical Assistant Professor
Clinical Pharmacist, Hematology-Oncology
University of Illinois at Chicago College of Pharmacy

 

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing.

Definitions

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

The faculty listed below has no relevant financial relationships with ineligible companies to disclose.

Joanna Martin, MD 

The faculty listed below have the following relevant financial relationships with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.

Patrick J. Fleming Jr., PharmD, BCOP
Epizyme: Speakers Bureau
GlaxoSmithKline: Speakers Bureau
Servier: Salary    

Christina Mactal Haaf, PharmD, BCOP, BCPS
BTG Specialty Pharmaceuticals: Honoraria
EUSA Pharma: Honoraria

Planner Disclosures

The planner listed below has the following relevant financial relationships with ineligible companies to disclose. All of the relevant financial relationships listed for this individual have been mitigated.

Christine B. Weldon, MBA
Eli Lilly and Company: Consulting Fee; Grant/Research Support
Genentech, Inc.: Consulting Fee; Grant/Research Support
Merck & Co., Inc.: Consulting Fee; Grant/Research Support
Pfizer Inc.: Consulting Fee; Grant/Research Support
Roche Pharmaceuticals: Consulting Fee; Grant/Research Support 

None of the other planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

image

In support of improving patient care, this activity has been planned and implemented by the National Comprehensive Cancer Network (NCCN) and Coleman Supportive Oncology Collaborative. NCCN is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
NCCN designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 0.5 contact hour.

Pharmacists
NCCN designates this knowledge-based continuing education activity for 0.5 contact hour (0.05 CEUs) of continuing education credit. UAN: JA4008196-9999-22-091-H01-P

Physician Assistants 
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. Approval is valid until August 4, 2024. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing